The UC College of Medicine, founded in 1819 by medical pioneer Daniel Drake, MD, is one of the oldest medical schools in the nation.
From graduate degrees to continuing education, the college offers a broad spectrum of educational opportunities.
The UC College of Medicine is continuing its upward path in cutting-edge research to enhance discovery sciences and facilitate translation of these discoveries to improve health and clinical care while recruiting new faculty. The new undergraduate program fosters scientific curiosity and investigation for our students. We are creating an environment of advanced clinical care that surpasses any in the region.
The College of Medicine features 26 academic departments, offering clinical, education and research opportunities.
The UC Cancer Institute focuses on disease-based centers of excellence to offer a multidisciplinary approach to cancer care, education and research.
The UC Gardner Neuroscience Institute provides advanced evidence-based treatment and active research of complex neurological conditions.
The UC Heart, Lung and Vascular Institute builds upon its nationally known cardiovascular diseases discoveries to make significant contributions to research, education and patient care.
The Center for Integrative Health and Wellness promotes the value of treating the whole person and works to provide evidence-based wellness initiatives across the Academic Health Center and into the community through education, research and clinical care.
The College of Medicine has identified four institutes in which we have outstanding quality, a track record of success, opportunities for funding and ability to advance translational research and deliver high-quality personalized care.
The University of Cincinnati College of Medicine is known for its strong educational programs. From medical degrees to summer research programs, the College of Medicine offers some of the most innovative and captivating science and research opportunities in the nation.
Monday, Apr. 24, 2017
Back To Dept.
In fulfilling its mission to protect public health, the Risk Science Center builds partnerships between industry and government to incorporate the best science in the development of risk assessment values and methods. Such partnerships provide the opportunity to leverage the scarce government funds that are available to keep up with the growing number of studies and improvements in risk methods. For example, it would take over 20 years in order to provide only one update to the over 500 chemicals on IRIS, given the current rate of reevaluations by the IRIS program. Involving scientists who are not government employees or government contractors in assessments can take advantage of expert knowledge on the individual chemical; outside scientists may also be given more time to fully explore all technical issues.
The Risk Science Center fosters partnerships in a number of ways:
- We can bring together two or more groups interested in a specific chemical, and provide informed and neutral guidance and advice.
- To an existing process we can provide ongoing neutral technical facilitation and oversight as needed.
- We can work with EPA to facilitate its review of an assessment prepared by us for an industry organization. This may result in EPA putting the chemical on its IRIS list, or even in EPA jointly sponsoring a portion of the assessment.
-ITER Peer Review Program provides an avenue for independent assessments to undergo rigorous review by a panel experts in risk assessment and other relevant fields from government, industry, and academia. After approval by the panel, these values are made widely available to the public at https://toxnet.nlm.nih.gov/newtoxnet/iter.htm.